1.Hall IC, OToole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935;49:390–402.
2.Bartlett JG, Chang T, Taylor NS, Onderdonk AB. Colitis induced by Clostridium difficile. Rev Infect Dis 1979;1:370–378.
3.Bartlett JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med 2002;346:334–339.
4.Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005;18:247–263.
5.Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390–397.
6.Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357:189–193.
7.McFarland LV. What's lurking under the bed? Persistence and predominance of particular Clostridium difficile strains in a hospital and the potential role of environmental contamination. Infect Control Hosp Epidemiol 2002;23:639–640.
8.Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100:32–40.
9.Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr.Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459–477.
10.Johnson S, Samore MH, Farrow KA, et al.Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. NEngl J Med 1999;341:1645–1651.
11.Layton BA, McDonald LC, Gerding DN, Liedtke LA, Strausbaugh IJ. Perceived increases in the incidence and severity of Clostridium difficile disease: an emerging threat that continues to unfold. Presented at the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 9-12, 2005; Los Angeles, CA. Abstract 66.
12.Dallai RM, Harbrecht BG, Boujoukas AJ, et al.Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363–372.
13.Pepin J, Valiquette L, Alary ME, et al.Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466–472.
14.McDonald L, Kilgore G, Thompson A, Johnson S, Gerding D. Emergence of an epidemic strain of Clostridium difficile in the United States 2001-4: potential role for virulence factors and antimicrobial resistance traits. Presented at the 42nd Annual Meeting of the Infectious Diseases Society of America; September 30-October 3, 2004; Boston, MA. Abstract LB-2.
15.Warny M, Pepin J, Fang A, Killgore G, Thompson A, McDonald LC. Increased toxins A and B production in an emerging strain of Clostridium difficile. Presented at the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 9-12, 2005; Los Angeles, CA. Abstract 313.
16.Eggertson L, Sibbald B. Hospitals battling outbreaks of C. difficile. CMAJ 2004;171:19–21.
17.Eggertson L. C. difficile: by the numbers. CMAJ 2004;171:1331–1332.
19.Sohn S, Climo M, Diekema D, et al.Varying rates of Clostridium difficile-associated diarrhea at Prevention Epicenter Hospitals. Infect Control Hosp Epidemiol 2005;26:676–679.
20.Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA. Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 2005; 26:680–684.
21.Modena S, Bearelly D, Swartz K, Friedenberg FK. Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol 2005;26:685–690.
22.Rexach CE, Tang-Feldman YJ, Cohen SH. Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California. Infect Control Hosp Epidemiol 2005;26:691–696.
23.Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189:1585–1589.
24.McDonald LC, Banerjee S, Jernigan DB. Increasing incidence of Clostridium difficile-associated disease in U.S. acute care hospitals, 1993-2001. Presented at the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA. Abstract 67.
25.Kralovic SM, Danko LH, Simbartl LA, Roselle GA. Clostridium difficile infection in VA medical centers nationwide. Presented at the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 9-12, 2005; Los Angeles, CA. Abstract 284.
26.Delmee M, Van Broeck J, Simon A, Janssens M, Avesani V. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 2005;54(part 2):187–191.
27.Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ 2004;171:51–58.
28.Gaynes R, Rimland D, Killum E, et al.Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004;38:640–645.
29.Muto CA, Pokrywka MF, Shutt K, et al.A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273–280.
30.Garner JS. Guideline for isolation precautions in hospitals: the Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:53–80.
31.Boyce JM, Pittet D. Guideline for hand hygiene in healthcare settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002;23(suppl):S3–S40.